Last reviewed · How we verify

NCT05523882

The Clinical Impact of POCUS Use in General Practice

Completed Last updated 21 February 2025
What this trial tests

trial testing point-of-care ultrasound in Point-of-care Ultrasound in 34 participants. Completed in 30 November 2024.

Timeline
31 August 2022
Primary endpoint
30 November 2024
30 November 2024

Quick facts

Lead sponsorAalborg University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment34
Start date31 August 2022
Primary completion30 November 2024
Estimated completion30 November 2024
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Aalborg University

Who can join

Eligibility, any sex, with Point-of-care Ultrasound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Being a hybrid type 2 effectiveness-implementation study, this study aims to simultaneous assess the clinical effectiveness of the introduction of point-of-care unltrasound in general practice and to measure the impact of the implementation strategy as co-primary aims.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of point-of-care ultrasound

Trials testing the same drug.

Other recruiting trials for Point-of-care Ultrasound

Currently open trials in the same condition.

Other Aalborg University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05523882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing